b**t
发帖数: 656 | 1 FDA approves Omontys to treat anemia in adult patients on dialysis The U.S
. Food and Drug Administration today approved (NASDAQ: AFFY) Omontys (
peginesatide) to treat anemia, a condition in which the body does not have
enough healthy red blood cells, in adult dialysis patients who have chronic
kidney disease. |
|
d**********r
发帖数: 24123 | 2 Affymax to delist from Nasdaq on June 6
Affymax disclosed in a regulatory filing that on May 28, the company
received a determination letter from Nasdaq indicating that Nasdaq believes
that the company should be delisted. Specifically, Nasdaq notified the
company that it is operating as a “public shell” and has determined that,
following the company’s announcement regarding the voluntary recall of
Omontys, the company no longer has an operating business. The company does
not plan to appeal the d... 阅读全帖 |
|
d**********r
发帖数: 24123 | 3 Affymax to delist from Nasdaq on June 6
Affymax disclosed in a regulatory filing that on May 28, the company
received a determination letter from Nasdaq indicating that Nasdaq believes
that the company should be delisted. Specifically, Nasdaq notified the
company that it is operating as a “public shell” and has determined that,
following the company’s announcement regarding the voluntary recall of
Omontys, the company no longer has an operating business. The company does
not plan to appeal the d... 阅读全帖 |
|
